Akelos Inc

Akelos Inc

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited Investors - Invest.AkelosInc.com

Founded 2018

New York, United States 5 employees Grant Total: $2.05M Biopharma, Biotechnology +2

Akelos Inc is a biopharmaceutical clinical company dedicated to developing innovative non-narcotic drugs for the treatment of neuropathic pain, aiming to address the significant unmet needs in this area. With over 21 million adults in the US alone suffering from neuropathic pain and associated costs exceeding $90 billion/year, the urgency for effective treatment is evident. Akelos has been actively working in collaboration with Weill Cornell Medicine, Columbia University, and Cornell University, leveraging their exclusive worldwide license with these institutions for the development of novel compounds targeting neuropathic pain. In January 2020, the company secured a $1.76M grant investment from the National Institutes of Health, emphasizing the recognition of Akelos' potential in combatting the opioid epidemic through their opioid alternatives. The company's innovative approach and strong partnerships position them as a key player in the efforts to revolutionize neuropathic pain treatment. With two drug candidates in pre-clinical development and a focus on translating innovative science into real-world treatments, Akelos Inc. presents an impactful opportunity for accredited investors seeking to contribute to addressing this critical healthcare challenge.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$1.76M	1	National Institutes of Health	22 Jan 2020
Seed Round	$295.00K	-		23 Oct 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$1.76M

National Institutes of Health

22 Jan 2020

Seed Round

$295.00K

23 Oct 2018

FAQ About Akelos Inc

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited Investors - Invest.AkelosInc.com

Akelos Inc was founded in 2018.

Akelos Inc is headquartered in New York, United States.

Akelos Inc operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical, neuropathic pain, opioid alternatives and drug development.

Akelos Inc has approximately 5 employees.

Akelos Inc has completed 2 funding rounds, raising a total of $2.05M. The latest funding stage is Grant.

Top alternatives and competitors to Akelos Inc include OrphoMed, Regulonix Holding, Inc., ZYUS Life Sciences, Centrexion Therapeutics Corp., Tafalgie Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Akelos Inc and OrphoMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Akelos Inc

Funding Rounds & Investors (2)

Akelos Inc Alternatives & Competitors

FAQ About Akelos Inc